ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta

Shi, Lin; Kan, Jun; Zhuo, Lin; Wang, Siyun; Chen, Shaobing; Zhang, Bei*; Ke, Bin*南方医科大学; 中山大学
FEBS Journal2023-2DOI: 10.1111/febs.16639
2被引4阅读
引用收藏
分享

摘要

Lung cancer is the most aggressive cancer with the highest mortality and incidence rates worldwide. MicroRNAs have been identified as potential targets for non-small cell lung cancer (NSCLC) treatment. However, the modulatory role of miR-514b-5p in NSCLC progression is little known. In the present study, miRNA expression datasets for NSCLC were downloaded from the Cancer Genome Atlas and Gene Ontology Omnibus databases. Gene expression was assessed using a quantitative real-time PCR, and western blot analysis and immunohistochemical staining was used to determine protein expression. Gain and loss of function experiments were performed to investigate the impact of miR-514b-5p and small glutamine-rich tetratricopeptide repeat-containing protein beta (SGTB) on cell proliferation and apoptosis. RNA immunoprecipitation and dual-luciferase assays were performed to analyse the target gene of miR-514b-5p. The biological roles of miR-514b-5p were lastly evaluated using nude mouse tumorigenicity assays in vivo. We found that miR-514b-5p was dramatically increased in NSCLC tissues and higher miR-514b-5p expression was associated with poorer overall survival in NSCLC patients. Furthermore, overexpression of miR-514b-5p promoted NSCLC cell growth and suppressed apoptosis by inducing the activation of the phosphatidylinositol-3-kinase (PI3K)/AKT and p38 signalling pathways. Mechanistically, dual-luciferase and the RNA immunoprecipitation results highlighted that SGTB was a target gene of miR-514b-5p. Moreover, overexpression of SGTB reduced cell division and promoted apoptosis in vitro through blocking the PI3K/AKT and p38 signalling pathways. Our findings indicated that miR-514b-5p contributes to carcinoma progression in NSCLC via the PI3K/AKT and p38 signalling pathways by targeting SGTB and this could be a promising diagnostic and therapeutic target for the treatment of NSCLC.

学科与关键词

关键词
bioinformatics analysismiR-514b-5pNSCLCPI3KAKT and p38 signalling pathwaysSGTB
相关
加载中…
  • MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non-small-cell Lung Cancer
    Zhao, MengYang*; Tang, ZiBo; Wang, YiJun; Ding, JiaoJiao; Guo, Ying; Zhang, Ning; Gao, TianHuiAmerican Journal of Cancer Research, 2021, 12(22): 6600-6609.被引 4
  • Overexpression of miR-328-5p influences cell growth and migration to promote NSCLC progression by targeting LOXL4
    Ji, Yanzhao; You, Yanting; Wu, Yifen; Wang, Min; He, Qiuxing; Zhou, Xinghong; Chen, Liqian; Sun, Xiaomin; Liu, Yanyan; Fu, Xiuqiong; Kwan, Hiu Yee; Zuo, Qiang; Luo, Ren*; Zhao, Xiaoshan*Annals of Translational Medicine, 2022, 10(6).被引 6
  • Long Noncoding RNA SNHG5 Induces the NF-KB Pathway by Regulating miR-181c-5p/CBX4 Axis to Promote the Progression of Non-Small Cell Lung Cancer
    Kang, Shiyang; Ou, Chaopeng; Yan, An; Zhu, Kaibin; Xue, Ruifeng; Zhang, Yingjun; Lai, Jielan*ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59(1): 10-18.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
FEBS Journal
发表日期
2023-02
卷期
第 290 卷, 第 4 期
页码
1134-1150
DOI
10.1111/febs.16639
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82074159, 81874381]; Natural Science Foundation of Guangdong Province of China [2021A1515011611, 2021A1515010491]

作者

  • S

    Shi, Lin (第一作者)

    southern med univ

  • K

    Kan, Jun

    sun yat sen univ

查看全部 7 位作者收起作者
  • Z

    Zhuo, Lin

    southern med univ

  • W

    Wang, Siyun

    southern med univ

  • C

    Chen, Shaobing

    southern med univ

  • Z

    Zhang, Bei (通讯)

    sun yat sen univ

  • K

    Ke, Bin (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417